New cancer clinical trial: A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer

Published on: November 01, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share